In 2023, Germany led global government expenditure on R&D in medical and health sciences with a significant year-on-year growth of 8.06%. Japan and Spain also showed substantial growth rates of 6.57% and 4.01%, respectively. In contrast, the United Kingdom and Netherlands experienced notable declines of -20.94% and -12.17%. Over the last five years, this sector has witnessed varying degrees of investment commitments, with a particular surge seen in Germany and mild yet consistent growth in regions like Taiwan and Russia.
Future trends to watch include the potential recovery of R&D investment in countries like the United Kingdom and Netherlands and the continued dominance of leading countries such as Germany and Japan. Advances in biotechnology, health information technology, and the need for rapid response to global health challenges may further influence expenditure patterns.
Top countries in Government Expenditure on R&D in Medical and Health Sciences Share by Country (Million US Dollars PPP = 2015)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 23 | 2023 | +6.79% | +8.06% | View data |
| 2 | 2 Japan | 17.52 | 2023 | +5.65% | +6.57% | View data |
| 3 | 3 Spain | 13.12 | 2023 | +4.5% | +4.01% | View data |
| 4 | 4 Russia | 10.52 | 2023 | +2.04% | +1.53% | View data |
| 5 | 5 Italy | 9.36 | 2023 | +1.28% | +2.93% | View data |
| 6 | 6 Taiwan | 8.93 | 2023 | +0.87% | +0.54% | View data |
| 7 | 7 Singapore | 4.14 | 2023 | +3.31% | +5.71% | View data |
| 8 | 8 South Korea | 3.82 | 2023 | +8.82% | +3.84% | View data |
| 9 | 9 Norway | 1.61 | 2023 | +2.43% | +1.76% | View data |
| 10 | 10 Portugal | 0.89 | 2023 | +1.74% | +3.83% | View data |
